SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-16-012913
Filing Date
2016-05-02
Accepted
2016-05-02 16:05:50
Documents
6
Period of Report
2016-06-16
Effectiveness Date
2016-05-02

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0416_soligenixinc.htm DEF 14A 377963
2 GRAPHIC img_01.jpg GRAPHIC 906
3 GRAPHIC img_02.jpg GRAPHIC 878
4 GRAPHIC img_001.jpg GRAPHIC 80402
5 GRAPHIC img_002.jpg GRAPHIC 243876
6 GRAPHIC img_003.jpg GRAPHIC 222738
  Complete submission text file 0001213900-16-012913.txt   1135705
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-16929 | Film No.: 161611679
SIC: 2834 Pharmaceutical Preparations